Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortus

Infection and Immunity

Volumn 67, Issue 2, 1999, Pages 986-988

  Onate, Angel A ^a   Vemulapalli, Ramesh ^c   Andrews, Edilia ^a   Schurig, Gerhardt G ^c   Boyle, Stephen ^c   Folch, Hugo ^b  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^c CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BACTERIUM ANTIBODY; BRUCELLA VACCINE; COPPER ZINC SUPEROXIDE DISMUTASE; THIOREDOXIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; BRUCELLA ABORTUS; CELL PROLIFERATION; ENZYME ANALYSIS; ESCHERICHIA COLI; FEMALE; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; VACCINATION;

EID: 0032913181     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.2.986-988.1999     Document Type: Article

References (14)

1. Beck, B. L., L. B. Tabatabai, and J. E. Mayfield. 1991. A protein isolated from Brucella abortus is a Cu-Zn superoxide dismutase. Biochemistry 29: 372-376.
2. Cheville, N. F., M. G. Stevens, A. E. Jensen, F. M. Tatum, and S. M. Halling. 1993. Immune response and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus. Am. J. Vet. Res. 54:1591-1597.
3. Jiménez de Bagüés, M. P., P. H. Elzer, S. M. Jones, J. M. Blasco, F. M. Enright, G. G. Schurig, and A. J. Winter. 1994. Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis. Infect. Immun. 62: 4990-4996.
4. Latimer, E., J. Simmers, N. Sriranganathan, M. Roop, G. G. Schurig, and S. M. Boyle. 1992. Brucella abortus deficient in copper/zinc superoxide dismutase is virulent in Balb/C mice. Microb. Pathog. 12:105-113.
5. Montaraz, J. A., and A. J. Winter. 1986. Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice. Infect. Immun. 53:245-251.
6. Oliveira, S. C., and G. A. Splitter. 1996. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 14:959-962.
7. Oñate, A., and H. Folch. 1995. 18.5 Kda protein: an interesting antigen of Brucella. Arch. Med. Vet. 27:93-102.
8. Schurig, G. G., R. M. Roop. T. Bagchi, S. Boyle, D. Buhrman, and N. Sriranganathan. 1991. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet. Microbiol. 28:171-188.
9. Snedecor, G. W., and W. G. Cochran. 1989 Statistical methods, 8th ed. Iowa State University, Ames.
10. Stevens, M. G., L. B. Tabatabai, C. S. Olsen, and N. F. Cheville. 1994. Immune response to superoxide dismutase and synthetic peptides of superoxide dismutase in cattle vaccinated with Brucella abortus strain 19 or RB51. Vet. Immunol. 41:383-389.
11. Stevens, M., G., S. C. Olsen, G. W. Pugh, Jr., and D. Brees. 1995. Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51. Infect. Immun. 63:264-270.
12. Tabatabai, L. B., and G. W. Pugh, Jr. 1994. Modulation of immune response in BALB/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine. Vaccine 12:919-924.
13. Tatum, F. M., P. G. Detilleux, J. M. Sacks, and S. M. Hailing. 1992. Construction of Cu-Zn superoxide dismutase deletion mutants of Brucella abortus: analysis of survival in vitro in epithelial and phagocytic cells and in vivo in mice. Infect. Immun. 60:2863-2869.
14. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.